ARLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...

No significant news for TLK in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...

Kala-azar disease is a disease caused by a parasite. According to WHO, it is fatal if left untreated in over 95% of cases. It is characterized by irregular bouts of fever, weight loss, enlargement ...

The disease is caused by a parasite, spread to humans through the bite of infected female sand flies. It attacks the immune system and is almost always fatal if not treated on time.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...